Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice
- PMID: 9278338
Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice
Abstract
IL-1alpha and IL-1beta are potent inflammatory cytokines that contribute to a number of normal physiologic processes and to the development of a number of inflammatory diseases. Two IL-1R, the type I and type II receptors, have been identified. This work describes the derivation and characterization of mice deficient in expression of the type I IL-1R (IL-1RI). IL-1RI-deficient mice were viable and fertile, but failed to respond to IL-1 in a variety of assays, including IL-1-induced IL-6 and E-selectin expression and IL-1-induced fever. Similar to IL-1beta-deficient mice, IL-1RI-deficient mice had a reduced acute phase response to turpentine. In contrast, IL-1RI-deficient mice had a reduced delayed-type hypersensitivity response and were highly susceptible to infection by Listeria monocytogenes. These data demonstrate that the IL-1RI is essential for all IL-1-mediated signaling events examined, and that both IL-1alpha and IL-1beta are critical to the animals' response to injury and infection. These data also demonstrate that IL-1 function is not required for normal development or homeostasis.
Similar articles
-
IL-1 receptor accessory protein is an essential component of the IL-1 receptor.J Immunol. 1998 Nov 15;161(10):5614-20. J Immunol. 1998. PMID: 9820540
-
Phenotypic and functional characterization of mice that lack the type I receptor for IL-1.J Immunol. 1997 Oct 1;159(7):3364-71. J Immunol. 1997. PMID: 9317135
-
Interleukin-1-mediated febrile responses in mice and interleukin-1 beta activation of NFkappaB in mouse primary astrocytes, involves the interleukin-1 receptor accessory protein.Eur Cytokine Netw. 1998 Jun;9(2):131-8. Eur Cytokine Netw. 1998. PMID: 9681388
-
Targeting interleukin-1 signaling in chronic inflammation: focus on P2X(7) receptor and Pannexin-1.Drug News Perspect. 2008 Oct;21(8):424-33. doi: 10.1358/dnp.2008.21.8.1265800. Drug News Perspect. 2008. PMID: 19034348 Review.
-
[In vitro and in vivo study of regulation mechanisms of type I interleukin-1 receptor].Yakugaku Zasshi. 2001 Jan;121(1):9-21. doi: 10.1248/yakushi.121.9. Yakugaku Zasshi. 2001. PMID: 11201166 Review. Japanese.
Cited by
-
The Nlrp3 Inflammasome Does Not Regulate Alloimmunization to Transfused Red Blood Cells in Mice.EBioMedicine. 2016 Jul;9:77-86. doi: 10.1016/j.ebiom.2016.06.008. Epub 2016 Jun 16. EBioMedicine. 2016. PMID: 27345021 Free PMC article.
-
Interleukin-1 receptor role in the viability of corneal myofibroblasts.Exp Eye Res. 2012 Mar;96(1):65-9. doi: 10.1016/j.exer.2011.12.022. Epub 2012 Jan 10. Exp Eye Res. 2012. PMID: 22251454 Free PMC article.
-
IL-1 beta signalling in glial cells in wildtype and IL-1RI deficient mice.Br J Pharmacol. 2002 May;136(2):312-20. doi: 10.1038/sj.bjp.0704715. Br J Pharmacol. 2002. PMID: 12010781 Free PMC article.
-
IL-1β suppresses innate IL-25 and IL-33 production and maintains helminth chronicity.PLoS Pathog. 2013;9(8):e1003531. doi: 10.1371/journal.ppat.1003531. Epub 2013 Aug 1. PLoS Pathog. 2013. PMID: 23935505 Free PMC article.
-
Regulation of type 17 helper T-cell function by nitric oxide during inflammation.Proc Natl Acad Sci U S A. 2011 May 31;108(22):9220-5. doi: 10.1073/pnas.1100667108. Epub 2011 May 16. Proc Natl Acad Sci U S A. 2011. PMID: 21576463 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials